UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4493) 4493
Magazine Article (16) 16
Newsletter (14) 14
Book Chapter (6) 6
Publication (2) 2
Dissertation (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3727) 3727
ceftriaxone - therapeutic use (3219) 3219
science & technology (2802) 2802
life sciences & biomedicine (2708) 2708
male (2333) 2333
female (1983) 1983
anti-bacterial agents - therapeutic use (1901) 1901
ceftriaxone (1431) 1431
adult (1334) 1334
middle aged (1154) 1154
infectious diseases (929) 929
aged (853) 853
ceftriaxone - administration & dosage (730) 730
antibiotics (679) 679
child (677) 677
treatment outcome (670) 670
adolescent (661) 661
microbiology (623) 623
pharmacology & pharmacy (582) 582
cephalosporins - therapeutic use (562) 562
child, preschool (525) 525
animals (516) 516
microbial sensitivity tests (503) 503
infant (493) 493
abridged index medicus (483) 483
ceftriaxone - pharmacology (436) 436
drug therapy, combination (427) 427
general & internal medicine (424) 424
medicine, general & internal (386) 386
anti-bacterial agents - pharmacology (378) 378
pediatrics (363) 363
anti-bacterial agents - administration & dosage (345) 345
cefotaxime - therapeutic use (328) 328
infections (324) 324
prospective studies (311) 311
bacterial infections - drug therapy (306) 306
ceftriaxone - adverse effects (304) 304
drug resistance (294) 294
aged, 80 and over (285) 285
gonorrhea - drug therapy (285) 285
immunology (280) 280
ceftriaxone sodium (267) 267
health aspects (266) 266
risk factors (265) 265
antimicrobial agents (256) 256
drug therapy (249) 249
retrospective studies (243) 243
diagnosis, differential (235) 235
research article (228) 228
neurosciences & neurology (224) 224
lyme disease - drug therapy (218) 218
bacteria (214) 214
patients (212) 212
research (212) 212
time factors (209) 209
care and treatment (207) 207
young adult (202) 202
drug therapy, combination - therapeutic use (197) 197
meningitis (196) 196
ciprofloxacin (195) 195
cefotaxime - analogs & derivatives (193) 193
ciprofloxacin - therapeutic use (193) 193
infant, newborn (191) 191
cephalosporins (186) 186
medicine (181) 181
anti-infective agents - therapeutic use (179) 179
pneumonia (177) 177
surgery (177) 177
analysis (175) 175
drug administration schedule (173) 173
injections, intravenous (172) 172
hospitals (171) 171
drug resistance, bacterial (166) 166
penicillins - therapeutic use (165) 165
ceftriaxone - pharmacokinetics (164) 164
antimicrobial resistance (163) 163
follow-up studies (158) 158
acute disease (155) 155
anti-bacterial agents - adverse effects (154) 154
doxycycline - therapeutic use (151) 151
neisseria gonorrhoeae - drug effects (151) 151
drug resistance in microorganisms (150) 150
internal medicine (149) 149
bacteremia - drug therapy (146) 146
azithromycin - therapeutic use (145) 145
gonorrhea (144) 144
meningitis, pneumococcal - drug therapy (143) 143
administration, oral (142) 142
magnetic resonance imaging (142) 142
meningitis, bacterial - drug therapy (142) 142
penicillin (142) 142
drug resistance, microbial (141) 141
mortality (140) 140
surgical wound infection - prevention & control (138) 138
metronidazole - therapeutic use (137) 137
mice (137) 137
neurosciences (137) 137
clinical neurology (134) 134
vancomycin - therapeutic use (134) 134
dosage and administration (133) 133
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4013) 4013
French (172) 172
Spanish (105) 105
German (95) 95
Japanese (78) 78
Italian (61) 61
Russian (30) 30
Portuguese (23) 23
Turkish (21) 21
Polish (13) 13
Chinese (12) 12
Dutch (12) 12
Hebrew (9) 9
Danish (7) 7
Finnish (7) 7
Romanian (6) 6
Czech (4) 4
Hungarian (4) 4
Bulgarian (3) 3
Korean (3) 3
Norwegian (2) 2
Serbian (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of clinical neuroscience, ISSN 0967-5868, 2006, Volume 13, Issue 8, pp. 857 - 859
Herein, we present a case of a parkinsonism–hyperpyrexia syndrome (PHS) in a 58-year-old man with a 10-year history of Parkinson’s disease. The patient... 
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Acyclovir - therapeutic use | Humans | Middle Aged | Male | Anxiety - drug therapy | Parkinson Disease - drug therapy | Antiparkinson Agents - therapeutic use | Anti-Bacterial Agents - therapeutic use | Depression - drug therapy | Carbidopa - therapeutic use | Pain - drug therapy | Anti-Inflammatory Agents - therapeutic use | Anxiety - complications | Pain - etiology | Depression - complications | Neuroleptic Malignant Syndrome - therapy | Acetaminophen - therapeutic use | Anti-Anxiety Agents - therapeutic use | Selegiline - therapeutic use | Parkinson Disease - complications | Cervical Vertebrae | Oxycodone - therapeutic use | Antiviral Agents - therapeutic use | Levodopa - therapeutic use | Analgesics, Opioid - therapeutic use | Neuroleptic Malignant Syndrome - complications | Analgesics, Non-Narcotic - therapeutic use | Spinal Injuries - complications | Dexamethasone - therapeutic use | Ceftriaxone - therapeutic use | Diazepam - therapeutic use | Electroconvulsive Therapy | Doxepin - therapeutic use | Parkinson Disease, complications | Oxycodone, therapeutic use | Neuroleptic Malignant Syndrome, therapy | Carbidopa, therapeutic use | Depression, complications | Pain, drug therapy | Spinal Injuries, complications | Selegiline, therapeutic use | Analgesics, Opioid, therapeutic use | Neuroleptic Malignant Syndrome, complications | Pain, etiology | Ceftriaxone, therapeutic use | Depression, drug therapy | Acetaminophen, therapeutic use | Parkinson Disease, drug therapy | Antiviral Agents, therapeutic use | Anti-Anxiety Agents, therapeutic use | Diazepam, therapeutic use | Anti-Inflammatory Agents, therapeutic use | Doxepin, therapeutic use | Anxiety, complications | Dexamethasone, therapeutic use | Levodopa, therapeutic use | Analgesics, Non-Narcotic, therapeutic use | Anxiety, drug therapy | Antiparkinson Agents, therapeutic use | Anti-Bacterial Agents, therapeutic use | Acyclovir, therapeutic use | Creatine | Creatine kinase | Parkinson's disease | Index Medicus
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 03/2012, Volume 56, Issue 3, pp. 1523 - 1528
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2012, Volume 56, Issue 3, pp. 1376 - 1381
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Conjugation, Genetic | Imipenem - therapeutic use | Cefoxitin - therapeutic use | Carbapenems - administration & dosage | Escherichia coli - drug effects | Humans | Ceftriaxone - pharmacology | Bacterial Load - drug effects | Cefoxitin - pharmacology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Carbapenems - pharmacology | beta-Lactamases - genetics | Ceftriaxone - administration & dosage | Female | Urinary Tract Infections - microbiology | Urinary Bladder - microbiology | beta-Lactamases - metabolism | Disease Models, Animal | Escherichia coli Infections - drug therapy | Imipenem - administration & dosage | Kidney - drug effects | Cefoxitin - administration & dosage | Drug Administration Schedule | Escherichia coli Infections - microbiology | Mutation Rate | Imipenem - pharmacology | Urinary Tract Infections - drug therapy | Kidney - microbiology | beta-Lactams - pharmacology | Animals | Ceftriaxone - therapeutic use | Carbapenems - therapeutic use | Escherichia coli - genetics | Plasmids | Urinary Bladder - drug effects | Anti-Bacterial Agents - pharmacology | Mice | beta-Lactams - therapeutic use | Anti-Bacterial Agents - administration & dosage | beta-Lactams - administration & dosage | Index Medicus | Experimental Therapeutics
Journal Article
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 09/2018, Volume 320, Issue 10, pp. 984 - 994
IMPORTANCE: Extended-spectrum β-lactamases mediate resistance to third-generation cephalosporins (eg, ceftriaxone) in Escherichia coli and Klebsiella... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Escherichia coli Infections - mortality | Klebsiella pneumoniae - drug effects | Escherichia coli - drug effects | Humans | Middle Aged | Drug Resistance, Bacterial | Bacteremia - mortality | Ceftriaxone - pharmacology | Male | Cause of Death | Anti-Bacterial Agents - therapeutic use | Penicillanic Acid - therapeutic use | Adult | Female | Anti-Bacterial Agents - adverse effects | Meropenem | Penicillanic Acid - adverse effects | Thienamycins - adverse effects | Penicillanic Acid - analogs & derivatives | Thienamycins - therapeutic use | Escherichia coli Infections - drug therapy | Klebsiella Infections - drug therapy | Piperacillin, Tazobactam Drug Combination | Bacteremia - drug therapy | Piperacillin - adverse effects | Klebsiella Infections - mortality | Aged | Anti-Bacterial Agents - pharmacology | Piperacillin - therapeutic use | Klebsiella | Treatment outcome | Safety and security measures | Tazobactam | Escherichia coli | Patient outcomes | Analysis | Comparative analysis | Risk factors | Bacterial infections | Intravenous administration | Mortality | Clinical trials | Piperacillin-tazobactam | Infections | Ceftriaxone | Drug resistance | Patients | Side effects | Cephalosporins | E coli | Piperacillin | Drug therapy | Blood diseases | Blood culture | Carbapenems | Index Medicus | Abridged Index Medicus | Original Investigation | Research
Journal Article